Latest news with #SidharthShukla
News18
2 days ago
- Health
- News18
Indians Move From Lipid Profile To Advanced Screening Tests Amid Rising Heart Attack Risk
Once thought of as something for people in their 50s and 60s, cardiac check-ups are being embraced by younger Indians. Labs are seeing people in their 20s and 30s visiting. The rising burden of heart diseases — coupled with the alarming rise of heart attacks among Indians — has triggered a national awakening around heart health. Diagnostic centres, digital health platforms, and radiologists alike are witnessing a clear trend: Indians are shifting from fragmented blood tests to comprehensive heart health check-ups, with advanced markers and imaging tests becoming integral to routine preventive care. In recent months, India has been shaken by the sudden loss of several well-known personalities to heart-related causes. In June alone, actress and model Shefali Jariwala, aged 42, collapsed from cardiac arrest, leaving fans stunned. Her passing follows those of TV star Sidharth Shukla (aged 40) and Kannada superstar Puneeth Rajkumar (46), both of whom succumbed to heart attacks in the past few years. The shock extended beyond entertainment: tech entrepreneur Sunjay Kapur, chairman of Sona Comstar, died of a heart attack at 51, while a young district-level boxer, aged 21-year-old, Mohit Sharm, collapsed mid-match, succumbing instantly to a suspected cardiac event. In fact, a 2025 autopsy study from BJ Medical College, Ahmedabad, published in National Journal of Basic and Applied Sciences, found that 44 per cent of examined hearts had advanced plaque buildup, and 15 per cent of people under 40 years already had severe atherosclerosis. India accounts for nearly one-fifth of the world's deaths due to heart attacks, and several studies warn that Indians experience cardiovascular disease almost a decade earlier than their Western counterparts. According to the diagnostic chain Agilus, demand for preventive heart health packages rose by 19 per cent in the last year, while the demand for standalone lipid profile testing fell by 2 per cent. 'A clear shift in heart health behaviour is underway as more people are choosing advanced cardiac risk screening instead of just basic cholesterol checks," Anand K, chief executive officer, Agilus Diagnostics told News18. 'Preventive health packages grew 19 per cent in volume as consumers increasingly opt for comprehensive, higher-value heart health checks. In contrast, traditional lipid profile test volumes fell by 2 per cent over the same period, further supporting the trend toward sophisticated risk diagnostics." Experts believe that today's consumer is informed and proactive. 'They are not just checking cholesterol; they are choosing risk markers that offer a fuller picture of heart health," Anand added. Younger patients are driving the demand The most striking development is the profile of those seeking preventive tests. Once thought of as something for people in their 50s and 60s, cardiac check-ups are now being embraced by younger Indians. Dr Sameer Bhati, former director, diagnostic chain Star Imaging and Path Lab, pointed out, 'We are seeing more and more young people in their 20s and 30s visiting diagnostic centres for preventive tests. Many are first-timers who never considered screening earlier." Bhati, who is now the director at Star Welfare and Foundation, said, 'Young age groups are increasingly interested in preventive heart screening. The proportion of 18 to 29-year customers increased from 5 per cent in 2023 to 10 per cent in 2025, to date." 'The age group between 30 to 39 years also increased from 15 per cent to 20 per cent over the same timeframe. Gender split remains consistent at around 60 per cent male and 40 per cent female," Bhati explained. For instance: In Delhi-NCR, the tier-2 suburbs of Gurugram and Ghaziabad now account for around 30 per cent of heart-health test volumes, from approximately 20 per cent in 2023." Data by deep-tech medical AI company, 5C Network – which deploys high-end AI and medical imaging technology in hospitals across India – shows that the share of patients under 40 years in cardiac imaging rose from 18 per cent in 2023 to 26 per cent in 2025 (to date). In fact, they noticed that in 2025, female participation is up by 5 per cent since 2023, with the latest data showing 63 per cent males and 37 per cent females coming for cardiac studies. Demand for advanced heart markers In an interesting shift, the traditional lipid profile and ECG are no longer enough for increasingly health-aware Indians. 'While lipid profile testing has maintained a steady presence, contributing 22–25 per cent of lifestyle-related disease tests, other cardiac risk marker tests have recorded a notable 34 per cent increase in uptake between 2024 and 2025," Aditya Kandoi, CEO and founder, Redcliffe Labs, told News18. 'Lipid monitoring remains a trusted baseline for preventive check-ups," Kandoi said while adding that '…. but, cardiac risk markers have moved a step further, as they help detect early inflammation and hidden risks, enabling proactive intervention before symptoms appear." 5C network's Kalyan also echoed a similar trend – a rise in demand for advanced imaging. One of the top five tests at 5C Network – which serves over 2,500 hospitals and diagnostic centres across India – is 'coronary calcium scoring" which is used to identify hard plaque in arteries, really seeing a pick up in numbers, primarily because of more awareness. 'Heart-related screening and diagnostic tests were up approximately 25 per cent. While chest X-rays went up in general, CT scan for calcium scoring and coronary angiogram saw a big jump," explained Kalyan Sivasailam, founder and CEO, 5C Network. He highlighted, 'Lipoprotein(a) and Apolipoprotein B are now not only in our advanced screening packages, but also being requested by customers directly." Similarly, Agilus' Anand explained that the demand for advanced heart health tests such as hs-CRP (high-sensitivity C-reactive protein), apolipoprotein B, lipoprotein(a), and troponin has gone up. 'These advanced markers help detect inflammation, genetic lipid disorders, and early heart muscle injury-critical risk factors often missed by standard cholesterol tests," he explained. How diagnostic landscape evolving? According to Redcliffe Labs, the diagnostic landscape in India has seen a steady rise in preventive testing over the last three years. Labs' data shows that the most commonly ordered tests in 2024 and 2025 remained consistent, with lipid profile, liver function, kidney function, diabetes-related tests and complete blood count (CBC) dominating the top five. 'Compared to 2023, the demand for these tests has grown steadily, reflecting a growing awareness about lifestyle-related conditions," Aditya Kandoi, chief executive officer, Redcliffe Labs, told News18. 'The increased adoption of preventive testing is an encouraging sign. It shows that people are not just seeking healthcare when they fall sick, but also prioritising regular monitoring to make informed lifestyle and treatment decisions." Overall, the stability of the top five tests over the years reflects how core diagnostics remain central to health management, while the rising volumes underscore India's shift towards preventive care. From Reactive to Proactive Health The overall movement is unmistakable: Indians are shifting from a reactive approach to healthcare — where tests followed symptoms — to a more proactive mindset of prevention. Data from Agilus confirms this, with a marked rise in comprehensive preventive health packages that go well beyond the traditional lipid profile. The trend is echoed by 5C Network, which shows growing demand for advanced cardiac imaging such as CT angiography and cardiac scans. Redcliffe Labs too sees increasing demand for next-generation biomarkers, including high-sensitivity CRP, homocysteine and apolipoproteins, tests that were once niche but are now entering the mainstream. top videos View all While the momentum is promising, experts caution that much of the surge in preventive cardiac testing remains urban-centric. 'Geographically, risk is not a metro‑only phenomenon. A study conducted by us showed a shallow urban–non‑urban gradient with abnormalities in Tier‑1 being approximately 51 per cent versus tier‑2/3 signalling 48 pe cent. It reflects that cardiovascular risk is widespread across India, and prevention strategies must be national in scope, not city‑centric," Kandoi from Redcliffe Labs added. For now, though, one thing is certain: heart health has moved from being a medical afterthought to a personal priority. And as more Indians sign up for check-ups, the hope is that early detection and lifestyle interventions can curb the country's growing cardiac burden. About the Author Himani Chandna Himani Chandna, Associate Editor at CNN News18, specialises in healthcare and pharmaceuticals. With firsthand insights into India's COVID-19 battle, she brings a seasoned perspective. She is particularly More Click here to add News18 as your preferred news source on Google. Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated! tags : Heart health heart-attack view comments Location : New Delhi, India, India First Published: August 20, 2025, 10:12 IST News india Indians Move From Lipid Profile To Advanced Screening Tests Amid Rising Heart Attack Risk Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy. Loading comments...
Hans India
02-07-2025
- Health
- Hans India
Major Studies Clear COVID Vaccines Of Sudden Death Links
Comprehensive research conducted by India's premier medical institutions has definitively ruled out any connection between COVID-19 vaccinations and unexpected deaths among young adults, following extensive investigations across multiple states. The Indian Council of Medical Research (ICMR) and the All India Institute of Medical Sciences (AIIMS) have concluded their nationwide studies, identifying lifestyle choices and underlying health conditions as the primary contributors to sudden fatalities rather than vaccination status. The Union Health Ministry issued an official statement Wednesday confirming that no association exists between COVID-19 immunizations and cardiac events in younger populations. This announcement followed Karnataka Chief Minister Siddaramaiah's suggestion that coronavirus vaccines might be connected to recent cardiac-related deaths in his state. These findings emerge amid growing concerns about increased heart attack incidents among adults under 40 across India. Recent years have witnessed several prominent personalities in their 40s and 50s succumbing to sudden cardiac events, including actor Sidharth Shukla at 40, singer KK at 53, actor Puneeth Rajkumar at 46, filmmaker Raj Kaushal at 50, and comedian Raju Srivastava at 58. The primary investigation, titled "Factors associated with unexplained sudden deaths among adults aged 18-45 years in India," spanned from May to August 2023 and encompassed 47 major hospitals across 19 states and union territories. Researchers focused on apparently healthy individuals who died unexpectedly between October 2021 and March 2023. A complementary study, "Establishing the cause of sudden unexplained deaths in young," was undertaken by AIIMS New Delhi with ICMR funding and collaboration, further strengthening the research foundation. Both investigations have conclusively demonstrated that COVID-19 vaccinations do not elevate the risk of unexplained sudden death among young adults. According to the official statement, sudden cardiac fatalities stem from diverse factors including genetic predisposition, lifestyle patterns, pre-existing medical conditions, and post-COVID complications. The research findings were released shortly after Karnataka's Chief Minister suggested that rapid COVID-19 vaccine approval and distribution might be linked to rising sudden death rates among young people in the state. His comments came following reports of at least 20 cardiac arrest deaths in Hassan district alone within the past month. Siddaramaiah also announced the establishment of a committee to examine potential COVID-19 vaccine side effects, prompting the Union Health Ministry's swift response. Medical experts emphasized that claims connecting COVID vaccination to sudden deaths lack scientific backing and contradict established medical consensus. The Health Ministry warned that speculative statements without concrete evidence could erode public trust in vaccines, which proved instrumental in saving millions of lives throughout the pandemic. Officials expressed concern that unfounded allegations might fuel vaccine hesitancy nationwide, potentially compromising public health initiatives. The statement underscored the importance of maintaining confidence in vaccination programs that have demonstrated significant effectiveness in combating the coronavirus pandemic. The timing of these findings coincides with a recent uptick in COVID cases across India, highlighting the continued relevance of vaccination programs in managing public health challenges.
Economic Times
01-07-2025
- Health
- Economic Times
Young and fit dropping dead: A sector comes into focus
The recent death of Shefali Jariwala, best known for the 2002 chartbuster 'Kaanta Laga', due to cardiac arrest, has again brought to light the increasing trend of young, healthy and fit Indians suddenly dying of heart attack. In the past few years, several celebrities, such as Sidharth Shukla and Puneeth Rajkumar, have died due to cardiac issues. Heart attack incidents which used to affect mainly older adults now appear with increasing frequency among people under 50 years of age. The epidemic of cardiovascular diseases in India has created a lot of awareness about timely diagnosis among people which puts the focus on an emerging segment in India's healthcare sector -- diagnostics. India's diagnostics sector is undergoing a significant transformation, shifting from a fragmented business to a structured and tech-driven industry. Recently, Amazon announced its foray into the diagnostics space, marking a defining moment in this evolution. With an estimated market size of $25 billion and rapid growth, diagnostics is emerging as one of the most promising segments in Indian healthcare. But what triggered this boom? What forces are shaping its future? And is there a link to the rise in sudden heart attacks among India's young population? The COVID-19 pandemic was a catalyst that brought diagnostics to the forefront of healthcare. Once seen as a backend service, diagnostic testing has now become integral to proactive health management. More Indians are choosing routine screenings and preventive tests over symptomatic treatment. The shift in mindset, from illness-based to wellness-based healthcare, has been profound. This behavioral transformation laid the groundwork for diagnostics to flourish across urban and semi-urban the pandemic, diagnostic players were overloaded with work. Their bottom lines were getting better every single quarter. Between FY20 and FY22 – in just two years – literally all the companies saw a growth of more than 50% in absolute revenue numbers, as per a recent ET report. Once the pandemic ended, the workload returned to normal. The cash generated during Covid was utilized by different companies in different ways. Some used it to reduce their debt burden, others used it for expansion, using the cash for mergers that turned them from regional to national players. Post-pandemic, the demand for diagnostic services has surged, not only because of higher health awareness but also due to the lingering effects of the virus, which prompted many to seek tests related to heart health, respiratory function, and immune markers. India's recent diagnostics growth is also closely linked to the rising incidence of non-communicable diseases (NCDs). Conditions such as cardiovascular diseases (CVD), diabetes, hypertension and cancer are being detected at younger ages and are increasingly prevalent even in tier-2 and tier-3 cities. This has naturally escalated the demand for laboratory tests and imaging services. There has been a noted increase in sudden heart attacks among young and seemingly fit Indians, especially post-COVID. While there is no direct data attributing this to the boom in diagnostics, the phenomenon has contributed to an increase in cardiovascular screenings such as lipid profiles, ECGs and stress tests. As more individuals seek to understand their cardiac risk, diagnostics have become a proactive tool for early detection. The Indian diagnostics sector is transitioning rapidly from unorganised, standalone labs to structured, pan-India diagnostic chains. Organised players such as Dr Lal PathLabs, Metropolis, Thyrocare and SRL Diagnostics are increasing their footprints through franchise models and acquisitions. Organised diagnostic labs currently command around 15% market share but this is rising steadily, according to a recent report by PhillipCapital. The market is characterized by a high degree of fragmentation, with hospital-based labs holding a 37% share and unorganized standalone labs controlling the remaining 48%. Amazon India's recent launch of its diagnostics service in collaboration with Orange Health Labs is a significant milestone for the sector. The service, currently available in six major cities and 450+ PIN codes, offers over 800 tests with home sample collection in under 60 minutes and reports delivered within six entry not only validates the sector's growth potential but also intensifies competition. Following Amazon's announcement, shares of major diagnostic players like Dr Lal PathLabs and Metropolis fell by up to 3%, reflecting market concerns about pricing pressures and customer retention. Amazon brings scale, tech infrastructure and a convenience-first model, which could redefine customer expectations in diagnostics, especially in urban centers. One of the most promising aspects of the diagnostics sector is its expansion beyond metros. Non-metro cities are witnessing an annual growth rate of 20–25% in diagnostics demand, compared to 10% in metro cities. Rising health awareness, increasing affluence, and better insurance penetration are enabling residents in smaller towns to opt for preventive testing. Organised players are aggressively entering these markets, setting up franchise labs, mobile collection centers and even partnering with local clinics to provide high-quality testing services. The demand surge from rural and semi-urban areas is expected to play a pivotal role in the sector's growth trajectory over the next five years. Recently, Suraksha Diagnostics said it will invest Rs 200 crore to set up over 20 advanced imaging centres across eastern India. The plan, which will be executed in collaboration with United Imaging, is aimed at expanding access to advanced diagnostic services in tier 2 and tier 3 cities, enhancing both affordability and healthcare quality in smaller towns and semi-urban regions, it said. The Indian government's healthcare initiatives, particularly Ayushman Bharat, have improved access to diagnostics for a broader population. Additionally, state-level Public-Private Partnership models in radiology, such as the Punjab government's tie-up with private players for operating MRI and CT scan centers, are helping bridge infrastructure insurance is also becoming more inclusive of diagnostics, covering pre-emptive testing and annual health checks. As out-of-pocket expenses decline, more individuals are accessing regular testing services, further supporting sectoral diagnostics sector remains under-penetrated compared to global standards. When measured by the number of tests conducted per person each year, India lags far behind other developing nations such as Brazil and Saudi Arabia--even though India has the largest population in the world. This indicates that there is still a huge untapped demand for diagnostics services in the country, as per the PhillipCapital report. The diagnostic sector in India is expected to grow at a compound annual growth rate (CAGR) of around 14% through FY2028, according to the PhillipCapital report. Radiology services alone are projected to expand from $7.1 billion in FY2025 to $13.5 billion by FY2030. The expansion will be led by increased adoption of AI in medical imaging, growth in home-based testing and broader genomic and personalised medicine challenges remain. Pricing pressures from new entrants like Amazon, quality standardisation in smaller labs and the need for improved regulation and accreditation are ongoing issues. The government and industry will need to work in tandem to ensure that growth does not compromise accuracy or Indian diagnostics sector is no longer an auxiliary healthcare service. It is becoming a central pillar of the country's healthcare ecosystem. Driven by lifestyle changes, epidemiological shifts, digital innovation, and consumer demand, the sector is poised for sustained expansion. Amazon's entry marks a shift from traditional models to a more consumer-focused, tech-enabled and scalable diagnostic future. While the rise in sudden heart attacks among the young has brought cardiovascular diagnostics into focus, the sector's momentum is supported by a much broader wave of preventive health consciousness sweeping the nation. Diagnostics in India is not just booming; it is evolving and preparing to redefine how 1.4 billion people manage their health.
Time of India
01-07-2025
- Health
- Time of India
Young and fit dropping dead: A sector comes into focus
The recent death of Shefali Jariwala , best known for the 2002 chartbuster ' Kaanta Laga ', due to cardiac arrest, has again brought to light the increasing trend of young, healthy and fit Indians suddenly dying of heart attack. In the past few years, several celebrities, such as Sidharth Shukla and Puneeth Rajkumar , have died due to cardiac issues. Heart attack incidents which used to affect mainly older adults now appear with increasing frequency among people under 50 years of age. The epidemic of cardiovascular diseases in India has created a lot of awareness about timely diagnosis among people which puts the focus on an emerging segment in India's healthcare sector -- diagnostics. India's diagnostics sector is undergoing a significant transformation, shifting from a fragmented business to a structured and tech-driven industry. Recently, Amazon announced its foray into the diagnostics space, marking a defining moment in this evolution. With an estimated market size of $25 billion and rapid growth, diagnostics is emerging as one of the most promising segments in Indian healthcare. But what triggered this boom? What forces are shaping its future? And is there a link to the rise in sudden heart attacks among India's young population? Changing mindsets and a pandemic-led shift Play Video Pause Skip Backward Skip Forward Unmute Current Time 0:00 / Duration 0:00 Loaded : 0% 0:00 Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 1x Playback Rate Chapters Chapters Descriptions descriptions off , selected Captions captions settings , opens captions settings dialog captions off , selected Audio Track Picture-in-Picture Fullscreen This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Text Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Transparent Caption Area Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Drop shadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Per i già clienti mobile TIM, Fibra fino a 2,5 Gbps, internet e chiamate illimitate da 24,90€/mese TIM Scopri di più Undo The COVID-19 pandemic was a catalyst that brought diagnostics to the forefront of healthcare. Once seen as a backend service, diagnostic testing has now become integral to proactive health management. More Indians are choosing routine screenings and preventive tests over symptomatic treatment. The shift in mindset, from illness-based to wellness-based healthcare, has been profound. This behavioral transformation laid the groundwork for diagnostics to flourish across urban and semi-urban India. During the pandemic, diagnostic players were overloaded with work. Their bottom lines were getting better every single quarter. Between FY20 and FY22 – in just two years – literally all the companies saw a growth of more than 50% in absolute revenue numbers, as per a recent ET report. Once the pandemic ended, the workload returned to normal. The cash generated during Covid was utilized by different companies in different ways. Some used it to reduce their debt burden, others used it for expansion, using the cash for mergers that turned them from regional to national players. Live Events Post-pandemic, the demand for diagnostic services has surged, not only because of higher health awareness but also due to the lingering effects of the virus, which prompted many to seek tests related to heart health, respiratory function, and immune markers. India's recent diagnostics growth is also closely linked to the rising incidence of non-communicable diseases (NCDs). Conditions such as cardiovascular diseases (CVD), diabetes, hypertension and cancer are being detected at younger ages and are increasingly prevalent even in tier-2 and tier-3 cities. This has naturally escalated the demand for laboratory tests and imaging services. There has been a noted increase in sudden heart attacks among young and seemingly fit Indians, especially post-COVID. While there is no direct data attributing this to the boom in diagnostics, the phenomenon has contributed to an increase in cardiovascular screenings such as lipid profiles, ECGs and stress tests. As more individuals seek to understand their cardiac risk, diagnostics have become a proactive tool for early detection. The Indian diagnostics sector is transitioning rapidly from unorganised, standalone labs to structured, pan-India diagnostic chains. Organised players such as Dr Lal PathLabs , Metropolis, Thyrocare and SRL Diagnostics are increasing their footprints through franchise models and acquisitions. Organised diagnostic labs currently command around 15% market share but this is rising steadily, according to a recent report by PhillipCapital. The market is characterized by a high degree of fragmentation, with hospital-based labs holding a 37% share and unorganized standalone labs controlling the remaining 48%. Amazon India's recent launch of its diagnostics service in collaboration with Orange Health Labs is a significant milestone for the sector. The service, currently available in six major cities and 450+ PIN codes, offers over 800 tests with home sample collection in under 60 minutes and reports delivered within six hours. This entry not only validates the sector's growth potential but also intensifies competition. Following Amazon's announcement, shares of major diagnostic players like Dr Lal PathLabs and Metropolis fell by up to 3%, reflecting market concerns about pricing pressures and customer retention. Amazon brings scale, tech infrastructure and a convenience-first model, which could redefine customer expectations in diagnostics, especially in urban centers. One of the most promising aspects of the diagnostics sector is its expansion beyond metros. Non-metro cities are witnessing an annual growth rate of 20–25% in diagnostics demand, compared to 10% in metro cities. Rising health awareness, increasing affluence, and better insurance penetration are enabling residents in smaller towns to opt for preventive testing. Organised players are aggressively entering these markets, setting up franchise labs, mobile collection centers and even partnering with local clinics to provide high-quality testing services. The demand surge from rural and semi-urban areas is expected to play a pivotal role in the sector's growth trajectory over the next five years. Recently, Suraksha Diagnostics said it will invest Rs 200 crore to set up over 20 advanced imaging centres across eastern India. The plan, which will be executed in collaboration with United Imaging, is aimed at expanding access to advanced diagnostic services in tier 2 and tier 3 cities, enhancing both affordability and healthcare quality in smaller towns and semi-urban regions, it said. The Indian government's healthcare initiatives, particularly Ayushman Bharat, have improved access to diagnostics for a broader population. Additionally, state-level Public-Private Partnership models in radiology, such as the Punjab government's tie-up with private players for operating MRI and CT scan centers, are helping bridge infrastructure gaps. Health insurance is also becoming more inclusive of diagnostics, covering pre-emptive testing and annual health checks. As out-of-pocket expenses decline, more individuals are accessing regular testing services, further supporting sectoral growth. What lies ahead for the diagnostic sector India's diagnostics sector remains under-penetrated compared to global standards. When measured by the number of tests conducted per person each year, India lags far behind other developing nations such as Brazil and Saudi Arabia--even though India has the largest population in the world. This indicates that there is still a huge untapped demand for diagnostics services in the country, as per the PhillipCapital report. The diagnostic sector in India is expected to grow at a compound annual growth rate (CAGR) of around 14% through FY2028, according to the PhillipCapital report. Radiology services alone are projected to expand from $7.1 billion in FY2025 to $13.5 billion by FY2030. The expansion will be led by increased adoption of AI in medical imaging, growth in home-based testing and broader genomic and personalised medicine offerings. However, challenges remain. Pricing pressures from new entrants like Amazon, quality standardisation in smaller labs and the need for improved regulation and accreditation are ongoing issues. The government and industry will need to work in tandem to ensure that growth does not compromise accuracy or ethics. The Indian diagnostics sector is no longer an auxiliary healthcare service. It is becoming a central pillar of the country's healthcare ecosystem. Driven by lifestyle changes, epidemiological shifts, digital innovation, and consumer demand, the sector is poised for sustained expansion. Amazon's entry marks a shift from traditional models to a more consumer-focused, tech-enabled and scalable diagnostic future. While the rise in sudden heart attacks among the young has brought cardiovascular diagnostics into focus, the sector's momentum is supported by a much broader wave of preventive health consciousness sweeping the nation. Diagnostics in India is not just booming; it is evolving and preparing to redefine how 1.4 billion people manage their health.
&w=3840&q=100)
First Post
30-06-2025
- Entertainment
- First Post
Priyanka Chopra 'shook' by 'Mujhse Shaadi Karogi' co-star Shefali Jariwala's demise: 'She was so young and...'
Several celebs before her who looked completely fine succumbed to heart disease. Actor Sidharth Shukla passed away due to cardiac arrest at 40 in September 2021 read more Actress and model Shefali Jariwala, who looked perfectly healthy, passed away at the age of 42 due to cardiac arrest. In fact, several celebs before her who looked completely fine succumbed to heart disease. Actor Sidharth Shukla passed away due to cardiac arrest at 40 in September 2021. And now, the actress' long-time doctor has issued a statement speaking to ABP news and revealed she had no serious medical condition and was undergoing anti-ageing treatment for the last five-six years. STORY CONTINUES BELOW THIS AD And now, her Mujhse Shaadi Karogi co-star Priyanka Chopra has condoled her untimely demise and written, 'So shook. She was too young. Sending condolences to Parag and family.' Varun Dhawan slams the paparazzi The actor wrote on Instagram- 'Again, one more passing of a soul being insensitively covered by the media. I just don't understand why do u have to cover someone's grief. Everyone looks so uncomfortable with this. How is this benefiting anyone? & my request to my friends in the media, this isn't the way someone would want their final journey covered.' Her sudden demise came across as a huge shock for everyone in the industry, along with her fans and admirers. The actress' last Twitter (X) post was about her close friend and former boyfriend Sidharth Shukla, as she shared a beautiful pic of them hugging each other at the Bigg House on his death anniversary. She captioned the pic, 'Thinking of you today mere dost @sidharth_shukla (heart emoji) (sic).'
